Minot Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$2.04M Sell
22,778
-14,815
-39% -$1.5M 0.53% 50
2022
Q1
$4.17M Sell
37,593
-5,078
-12% -$536K 0.9% 31
2021
Q4
$4.41M Sell
42,671
-3,953
-8% -$458K 0.85% 33
2021
Q3
$5.84M Buy
46,624
+4,188
+10% +$542K 1.26% 24
2021
Q2
$5.41M Buy
42,436
+2,489
+6% +$313K 1.18% 27
2021
Q1
$4.72M Buy
39,947
+3,736
+10% +$438K 1.2% 31
2020
Q4
$4.24M Buy
36,211
+8,945
+33% +$985K 1.27% 31
2020
Q3
$2.83M Buy
27,266
+235
+0.9% +$23.6K 1.07% 40
2020
Q2
$2.48M Buy
27,031
+10
+0% +$959 1.24% 31
2020
Q1
$2.44M Sell
27,021
-1,039
-4% -$111K 1.75% 17
2019
Q4
$3.4M Buy
+28,060
New +$3.08M 1.55% 16

Other funds holding MDT

Minot Wealth Management's MDT Position: Q2 2022 in Review

Minot Wealth Management reduced its Medtronic (MDT) stake by 39% in Q2 2022, selling an estimated $1.5M and leaving 22,778 shares worth $2.04M. The position accounts for 0.53% of the portfolio, ranked #50.

Minot Wealth Management first reported a position in MDT in Q4 2019 and has held it in 11 quarters since. The position peaked at $5.84M in Q3 2021. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • Minot Wealth Management held 22,778 shares of Medtronic worth $2.04M as of Q2 2022.
  • Minot Wealth Management sold 14,815 Medtronic shares in Q2 2022, an estimated $1.5M.
  • Medtronic made up 0.53% of Minot Wealth Management's portfolio in Q2 2022, its #50 holding.
  • Minot Wealth Management first reported a position in Medtronic in Q4 2019 and has held it in 11 quarters since.
  • Minot Wealth Management's Medtronic position peaked at $5.84M in Q3 2021.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Minot Wealth Management's 13F filing for Q2 2022, filed 12 Jul 2022.